Opportunity
Federal Register #B-86-2026
Proposed Peptide Manufacturing Activity at PolyPeptide Laboratories Inc. in FTZ 202
Posted
July 21, 2026
Respond By
August 31, 2026
Identifier
B-86-2026
NAICS
325412
This notice concerns proposed production activity at PolyPeptide Laboratories Inc. in Torrance, California, under the oversight of the Department of Commerce's Foreign-Trade Zones Board. - Government Buyer: - Department of Commerce, Foreign-Trade Zones Board - OEMs and Vendors: - PolyPeptide Laboratories Inc. (facility operator and manufacturer) - Products/Services Requested: - Manufacture of peptide products, including: - Liraglutide (sodium) - Nectin - Linaclotide - Use of various foreign-status materials and components, such as: - Fmoc-linker - Phenylalanine - Threonine - Histidine - Diisopropylcarbodiimide - Tryptophan - MBH-Br Resin - Rink Amide-MBHA Resin - 2CTC Resin - Unique or Notable Requirements: - Activity is within Foreign-Trade Zone 202, subject to FTZ regulations - Duty rates for materials range from duty-free to 6.5%, with some subject to special duties depending on country of origin - Public comment period is open regarding the proposed activity - No other specific OEMs or vendors are mentioned beyond PolyPeptide Laboratories Inc.
Description
This notice announces the proposed production activity at PolyPeptide Laboratories Inc. located in Torrance, California, within Foreign-Trade Zone 202. The production involves peptides including liraglutide, sodium; nectin; linaclotide; and other peptides, using specific foreign-status materials and components. The notice invites public comment on the proposed activity and outlines the duty rates and regulatory compliance related to the materials used. The activity is intended to benefit from FTZ procedures as explained on the Board's website.